Leblanc, Pierre
Harvard University · McLean Hospital
3 papers on CoChatORCID 0000-0001-8756-2396
Most cited papers
- Verified
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences
Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers
Cited by 1,099
- Verified
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
Schweitzer, J. S., Song, B., Herrington, T. M., Park, T.-Y., Lee, N., Ko, S., Jeon, J., Cha, Y., Kim, K., Li, Q., et al. (2020) · New England Journal of Medicine
Pluripotent Stem Cells ResearchParkinson's Disease Mechanisms and Treatments
Cited by 542
- Verified
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease
Park, T.-Y., Jeon, J., Lee, N., Kim, J., Song, B., Kim, J.-H., Lee, S.-K., Liu, D., Cha, Y., Kim, M., et al. (2023) · Nature
Parkinson's Disease Mechanisms and TreatmentsPluripotent Stem Cells Research
Cited by 128
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free